TATACHEM Tata Chemicals Q4 FY25 results (Jan–Mar 2025) and concall
Tata Chemicals faced a challenging Q4 FY25 characterized by significant global soda ash pricing pressure and restructuring costs in the UK. While India and Kenya showed volume resilience, the US business struggled with export margin compression in Southeast Asia. Management is pivoting towards a lower CAPEX cycle in FY26, focusing on operational efficiency and debt reduction as major expansion projects in India and the UK (pharma salt) come online.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 3,999 | 3,590 | 3,509 |
| EBITDA | 618 | 434 | 327 |
| Net profit | 267 | -21 | -49 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
